These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 11315597

  • 1. Predictive value of technetium-99m sestamibi in patients with multiple myeloma and potential role in the follow-up.
    Pace L, Catalano L, Del Vecchio S, Di Gennaro F, De Renzo A, Sica G, Califano C, Tedesco N, Borrelli G, Rotoli B, Salvatore M.
    Eur J Nucl Med; 2001 Mar; 28(3):304-12. PubMed ID: 11315597
    [Abstract] [Full Text] [Related]

  • 2. Different patterns of technetium-99m sestamibi uptake in multiple myeloma.
    Pace L, Catalano L, Pinto A, De Renzo A, Di Gennaro F, Califano C, Del Vecchio S, Rotoli B, Salvatore M.
    Eur J Nucl Med; 1998 Jul; 25(7):714-20. PubMed ID: 9662593
    [Abstract] [Full Text] [Related]

  • 3. Technetium-99m sestamibi scintigraphy is sensitive and specific for the staging and the follow-up of patients with multiple myeloma: a multicentre study on 397 scans.
    Mele A, Offidani M, Visani G, Marconi M, Cambioli F, Nonni M, Catarini M, Brianzoni E, Berbellini A, Ascoli G, Brunori M, Agostini V, Corvatta L, Isidori A, Spinelli A, Gradari M, Leoni P.
    Br J Haematol; 2007 Mar; 136(5):729-35. PubMed ID: 17233770
    [Abstract] [Full Text] [Related]

  • 4. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in the prediction of outcome of patients with multiple myeloma: a comparative study.
    Fonti R, Pace L, Cerchione C, Catalano L, Salvatore B, De Luca S, Pane F, Salvatore M, Del Vecchio S.
    Clin Nucl Med; 2015 Apr; 40(4):303-8. PubMed ID: 25608167
    [Abstract] [Full Text] [Related]

  • 5. Tc-99m MIBI scintigraphy in multiple myeloma: prognostic value of different Tc-99m MIBI uptake patterns.
    Bacovsky J, Myslivecek M, Scudla V, Koranda P, Buriankova E, Minarik J, Pika T, Zapletalova J.
    Clin Nucl Med; 2010 Sep; 35(9):667-70. PubMed ID: 20706038
    [Abstract] [Full Text] [Related]

  • 6. Staging and therapy monitoring of multiple myeloma by 99mTc-sestamibi scintigraphy: a five year single center experience.
    Villa G, Balleari E, Carletto M, Grosso M, Clavio M, Piccardo A, Rebella L, Tommasi L, Morbelli S, Peschiera F, Gobbi M, Ghio R.
    J Exp Clin Cancer Res; 2005 Sep; 24(3):355-61. PubMed ID: 16270521
    [Abstract] [Full Text] [Related]

  • 7. The value of 99mTc-MIBI whole body scintigraphy in active and in remission multiple myeloma.
    Fallahi B, Saghari M, Fard Esfahani A, Eftekhari M, Iravani M, Beiki D, Dabbagh Kakhki VR, Sadeghi R.
    Hell J Nucl Med; 2005 Sep; 8(3):165-8. PubMed ID: 16390023
    [Abstract] [Full Text] [Related]

  • 8. 99mTc-MIBI scintigraphy in untreated stage III multiple myeloma: comparison with X-ray skeletal survey and bone scintigraphy.
    Alper E, Gurel M, Evrensel T, Ozkocaman V, Akbunar T, Demiray M.
    Nucl Med Commun; 2003 May; 24(5):537-42. PubMed ID: 12717071
    [Abstract] [Full Text] [Related]

  • 9. Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma.
    Fonti R, Del Vecchio S, Zannetti A, De Renzo A, Di Gennaro F, Catalano L, Califano C, Pace L, Rotoli B, Salvatore M.
    Eur J Nucl Med; 2001 Feb; 28(2):214-20. PubMed ID: 11303893
    [Abstract] [Full Text] [Related]

  • 10. Multiple myeloma: predictive value of Tc-99m MIBI scintigraphy and MRI in its diagnosis and therapy.
    Myslivecek M, Nekula J, Bacovsky J, Scudla V, Koranda P, Kaminek M.
    Nucl Med Rev Cent East Eur; 2008 Feb; 11(1):12-6. PubMed ID: 19173182
    [Abstract] [Full Text] [Related]

  • 11. Technetium-99m-sestamibi scintigraphy in multiple myeloma and related gammopathies: a useful tool for the identification and follow-up of myeloma bone disease.
    Balleari E, Villa G, Garrè S, Ghirlanda P, Agnese G, Carletto M, Clavio M, Ferrando F, Gobbi M, Mariani G, Ghio R.
    Haematologica; 2001 Jan; 86(1):78-84. PubMed ID: 11146575
    [Abstract] [Full Text] [Related]

  • 12. [18F-FDG PET/CT and 99mTc-MIBI scintigraphy in evaluation of patients with multiple myeloma and monoclonal gammopathy of unknown significance: comparison of methods].
    Myslivecek M, Bacovský J, Scudla V, Koranda P, Minarík J, Buriánková E, Formánek R, Zapletalová J.
    Klin Onkol; 2010 Jan; 23(5):325-31. PubMed ID: 21061682
    [Abstract] [Full Text] [Related]

  • 13. Washout of [99mTc] sestamibi in predicting response to chemotherapy in patients with multiple myeloma.
    Pace L, Catalano L, Del Vecchio S, De Renzo A, Fonti R, Salvatore B, Andretta C, Di Nuzzo C, Rotoli B, Salvatore M.
    Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):281-5. PubMed ID: 16172574
    [Abstract] [Full Text] [Related]

  • 14. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
    Fonti R, Salvatore B, Quarantelli M, Sirignano C, Segreto S, Petruzziello F, Catalano L, Liuzzi R, Rotoli B, Del Vecchio S, Pace L, Salvatore M.
    J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
    [Abstract] [Full Text] [Related]

  • 15. 99mTc-MIBI whole body scintigraphy and P-glycoprotein for the prediction of multiple drug resistance in multiple myeloma patients.
    Fallahi B, Beiki D, Mousavi SA, Gholamrezanezhad A, Eftekhari M, Fard-Esfahani A, Alimoghaddam K, Mirpour S, Eskandarian A, Saghari M.
    Hell J Nucl Med; 2009 Feb; 12(3):255-9. PubMed ID: 19936339
    [Abstract] [Full Text] [Related]

  • 16. Technetium-99m-sestamibi scintigraphy: an alternative approach for diagnosis and follow-up of active myeloma lesions after high-dose chemotherapy and autologous stem cell transplantation.
    Svaldi M, Tappa C, Gebert U, Bettini D, Fabris P, Franzelin F, Osele L, Mitterer M.
    Ann Hematol; 2001 Jul; 80(7):393-7. PubMed ID: 11529464
    [Abstract] [Full Text] [Related]

  • 17. Technetium-99m 2-methoxy-isobutyl-isonitrile uptake scintigraphy in detection of the bone marrow infiltration in multiple myeloma: correlation with MRI and other prognostic factors.
    Erten N, Saka B, Berberoglu K, Turkmen C, Unal S, Bakir B, Yekeler E, Besisik SK.
    Ann Hematol; 2007 Nov; 86(11):805-13. PubMed ID: 17684742
    [Abstract] [Full Text] [Related]

  • 18. Value of Tc-99m sestamibi scintigraphy in the detection of bone lesions in multiple myeloma: comparison with Tc-99m methylene diphosphonate.
    Alexandrakis MG, Kyriakou DS, Passam F, Koukouraki S, Karkavitsas N.
    Ann Hematol; 2001 Jun; 80(6):349-53. PubMed ID: 11475149
    [Abstract] [Full Text] [Related]

  • 19. Comparison of Tc-99m sestamibi and TI-201 uptake in multiple myeloma.
    Chun KA, Cho IH, Won KC, Lee KH, Lee HW, Hyun MS, Hayashida K.
    Clin Nucl Med; 2001 Mar; 26(3):212-5. PubMed ID: 11245112
    [Abstract] [Full Text] [Related]

  • 20. Scintigraphy with technetium-99m methoxyisobutylisonitrile in multiple myeloma patients: correlation with the International Staging System.
    Koutsikos J, Grigoraki V, Athanasoulis T, Velidaki A, Mamoulakis C, Zomas A, Anagnostopoulos N, Georgiou E, Dimopoulos MA, Zerva C.
    Hell J Nucl Med; 2006 Mar; 9(3):177-80. PubMed ID: 17160159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.